Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Pediatrics/Neonatology | Pulmonary/Respiratory Diseases
Disease Category: Asthma (Pediatric)
Trial Information
A 12-week, randomized, double blind, active-controlled, multi-center, phase IIIb study comparing the efficacy and evaluating the safety of an investigational medication in adult and adolescent Hispanic subjects with asthma.
If you are Hispanic and living with asthma.
Amedica Research Institute and Dr. Carmen Molina are studying
the safety and effectiveness of a study medication for the
treatment of asthma in the Hispanic population.
To be eligible to participate in this clinical research study,
you must be Hispanic, take asthma medication daily, and be at least
12 years old.
Participants will receive study-related medical care and
study-related medication at no cost. Health insurance is not
needed. Compensation for time and travel may be offered.
To determine if you or your child are eligible, please call
305-681-7789.
Patient Inclusion Criteria:
- Male or Female, Hispanic (self-reported), older then 12 years
old.
- Diagnosis of asthma
Patient Exclusion Criteria:
- Been hospitalized at least once or required emergency treatment
more than once for an asthma related condition in the previous 6
months.
Maricarmen Porras Mirabal, CCRC
Amedica Research Institute, Inc.
625 E. 49th Street
Hialeah, FL 33013
Phone: 305-681-7789
Fax: 305-681-7968
EMail: coordinator@amedicaresearch.com
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
